From Skin to Brain: A Parkinson's Disease Patient Transplanted with His Own Cells
- PMID: 32619520
- DOI: 10.1016/j.stem.2020.06.008
From Skin to Brain: A Parkinson's Disease Patient Transplanted with His Own Cells
Abstract
In a pioneering study in New England Journal of Medicine, Schweitzer et al. (2020) report on a patient with Parkinson's disease who received a graft of dopamine neurons obtained from in vitro differentiated induced pluripotent stem cells, derived from the patient's own skin fibroblasts, showing the feasibility of autologous transplantation for dopamine cell replacement.
Copyright © 2020 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of Interests M.P. is the owner of Parmar Cells AB and co-inventor of the US patent application 15/093,927 owned by Biolamina AB, 16/610,787 owned by New York Stem Cell Foundation, and EP17181588 owned by Miltenyi Biotec. M.P. receives research funding from Novo Nordisk.
Comment on
-
Personalized iPSC-Derived Dopamine Progenitor Cells for Parkinson's Disease.N Engl J Med. 2020 May 14;382(20):1926-1932. doi: 10.1056/NEJMoa1915872. N Engl J Med. 2020. PMID: 32402162 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical